Major gaps in current understanding of coagulation and the pressing need for improved diagnostics and therapeutics lead @CHToh1 and @yongjxjason to propose a new convergent model of coagulation that integrates inflammation and innate immune activation.
https://t.co/TsutYTMcYU
Fibrinogen buffers the cytotoxicity of circulating histones in vivo and ratios of histones to fibrinogen help identify critically ill patients at highest risk of mortality, who might benefit from anti-histone therapy.
@CHToh1@stabrams@yongjxjason
https://t.co/dFR7Klnl44
Fibrinogen buffers the cytotoxicity of circulating histones in vivo and ratios of histones to fibrinogen help identify critically ill patients at highest risk of mortality, who might benefit from anti-histone therapy.
@CHToh1@stabrams@yongjxjason
https://t.co/dFR7KlmNew
Profound harm has been done to the individuals and families affected by infected blood.
For many, the inquiry’s report has sadly come too late, but its recommendations can still stop a growing complacency over transfusion practices @CHToh1@Elisagree
https://t.co/E6ML1Ph0cZ
Congratulations to Professor Cheng-Hock Toh who has been honoured with a Lifetime Achievement Award by the British Society for Haematology (BSH) in recognition of his outstanding contributions in the field of haematology.
Read more: https://t.co/80NzNZiKOl
#TeamLivUni
Writing in @bmj_latest, former RCP academic vice president Prof Cheng-Hock Toh CBE (@CHToh1) and colleagues describe the ‘rewarding and worthwhile career’ that clinical research can offer to doctors:
https://t.co/EkjZkcpE5W
Delighted to make the front cover of the @bmj_latest today. Thank you @CHToh1 for your support in developing this manuscript and for your support in initiating and growing @HaemSTAR_UK
🎉🎉 Congratulations to our BSH Lifetime Achievement Award winners; Mike Makris and Cheng Hok-Toh who have both made massive contributions to the world of Haematology throughout their careers 🎉🎉
#BSH24#BSH2024#BSHASM
📢We're seeking an enthusiastic #PDRA to join the team of Professor Cheng-Hock Toh on an NHS founded project in partnership with the Cryo-EM team of Leeds University.
Information / Apply ➡️https://t.co/XOjsx8Dy45
@LivUni_IVES@LivUniHLS@LivUniResearch
A recent paper in @JTHjournal illustrates research by @LivUni researchers to understand the mechanisms causing rare adverse reactions following the COVID vaccination.
Read the paper here⬇️
https://t.co/mSidrKAMBU
Will Lester chairs our Sunday afternoon session on the Top Abstracts with Expert Perspective: Thrombosis and Haemostasis, with six speakers #BSH24
Full programme is available on our conference website here: https://t.co/pDCzpLZ5B7
For #aprilfoolsday#Coverart
Adenoviral vector-based #COVID19#VITT is rare but carries significant risks of mortality and long-term morbidity.
Abrams et al @CHToh1 find 📈proinflammatory cytokines & Thelper 1/2 activation.
#CovidVaccines
https://t.co/31PwFN7FFl
Our former academic VP @CHToh1 reflects on his journey as a Malaysian medic in the British medical system while celebrating the #LunarNewYear.
He is joined by colleagues from the Malaysian–Chinese diaspora to discuss their own stories and experiences: https://t.co/mMezrA5as2
📸 Professor Nigel Cunliffe visited Windsor Castle today to receive his OBE for services to infectious disease and vaccine research from The Princess Royal.
🎉 Congratulations Nigel from everyone in HLS, we hope you've had a wonderful day! ❤️
➡️ https://t.co/XsD5ColJJm
Really helpful review in our latest issue by @CHToh1 and Jeremy Schofield on how to manage acute thrombosis and thrombocytopenia. https://t.co/xSkFSyrtBW
It's #InternationalWomensDay! 7/10 of our committee are women, incredible women at that! Read about them at https://t.co/b6HRMZh7qm
The committee is a fantastic mix of talent giving creativity and perspective. As a result, important haem-obs projects are in the pipeline. https://t.co/YDWGbtyq7O
@rjshaw64 presents data from ConNeCT, a questionnaire based study of long term neuro complications of TTP. 9 centres in UK open. 130 patients recruited so far. < half patients could return to the same job role/hours after diagnosis. 30% mod-severe depression. #HaemSTARUpdate
Embedding research in the NHS to improve outcomes for patients is now on a statutory footing.
However, priority actions are needed—as outlined here by @CHToh1 & Richard Haynes: https://t.co/5wd5GzwE7U
New research article> #Xpert Ultra testing of blood in severe #HIV-associated #tuberculosis to detect and measure #Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study https://t.co/Nhi0py3ryo #BSI#TB